| Aug 3 |
GSK's (LON:GSK) Dividend Will Be £0.15
|
| Aug 2 |
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
|
| Aug 2 |
GSK declares $0.3843 dividend
|
| Aug 2 |
GSK Insiders Added UK£472.6k Of Stock To Their Holdings
|
| Aug 1 |
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
|
| Aug 1 |
GSK wins FDA nod to expand Jemperli label in uterine cancer
|
| Aug 1 |
Who's to blame as Moderna's stock falls amid slashed guidance?
|
| Jul 31 |
GSK Q2 Earnings Review: Vaccine Issues Aside, A Strong Quarter
|
| Jul 31 |
GSK: Good Earnings Report, But Risks Ahead (Rating Downgrade)
|
| Jul 31 |
GSK plc (GSK) Q2 2024 Earnings Call Transcript
|
